急性期用脳室ドレーン市場：患者タイプ別、用途別-2025-2030年の世界予測

急性期用脳室ドレーン市場は、2023年に2億4,346万米ドルと評価され、2024年には2億6,664万米ドルに達すると予測され、CAGR 9.95%で成長し、2030年には4億7,319万米ドルになると予測されています。

急性期用脳室ドレーン（EVD）システムは、外傷性脳損傷や水頭症などの状態で脳室から脳脊髄液（CSF）を迂回させて頭蓋内圧を管理するために設計された重要な装置です。EVDの必要性は、頭蓋内圧の上昇による神経細胞の損傷を防ぐために迅速な介入が必要とされる急性期の臨床現場で生じる。EVDの主な用途は、脳神経外科、集中治療室、救急医療で、病院や神経専門センターなどのエンドユーザーに使用されています。EVDの市場成長は、神経疾患の罹患率の上昇、神経外科手術の進歩、新興国におけるヘルスケアインフラの整備が進んでいることなどに大きく影響されています。さらに、神経疾患に罹患しやすい老年人口の増加が需要をさらに促進しています。同市場の主要な消費者は、医療予算が増加している未開拓の地域で潜在的なビジネスチャンスを探り、スマート・モニタリング・システムの統合などの技術的進歩を活用してケアを強化することができます。しかし、この市場は、設置やメンテナンスに伴うコストの高さ、潜在的な感染リスク、これらのシステムを効果的に扱う熟練した専門家の不足といった点で限界に直面しています。イノベーションは、安全性とモニタリング機能を強化した、費用対効果が高く侵襲性の低いEVDシステムの開発に焦点を当てることができると思われます。また、感染リスクを低減し、装置の寿命を延ばす材料技術の研究も考えられます。とはいえ、市場関係者は厳しい規制遵守の課題に対処し、EVDシステムの管理スキルを高めるための研修プログラムを重視すべきです。EVD市場の性質は高度に専門化されているため、医療機器メーカーとヘルスケアプロバイダーが継続的に協力し、イノベーションを促進し、進化する臨床需要に合わせてサービスを調整する必要があります。まとめると、コスト削減、技術統合、新興国市場への進出に戦略的に焦点を当てることで、市場への参入と効果を大幅に高めることができます。

市場力学：急速に進化する急性期用脳室ドレーン市場の主要市場インサイトを公開

急性期用脳室ドレーン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の非外傷性水頭症の有病率
  • 患者の神経学的状態のモニタリングと調整の必要性
  • 患者の低侵襲医療への傾斜
• 市場抑制要因
  • 治療期間と時間が不確定であること
• 市場機会
  • EVD植え込みのためのリアルタイム超音波ナビゲーション使用の増加
  • 世界の医療ツーリズムの増加
• 市場の課題
  • 急性期用脳室ドレーンに関連するリスク

ポーターのファイブフォース：急性期用脳室ドレーン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、急性期用脳室ドレーン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：急性期用脳室ドレーン市場における外部からの影響の把握

外部マクロ環境要因は、急性期用脳室ドレーン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析急性期用脳室ドレーン市場における競合情勢の把握

急性期用脳室ドレーン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス急性期用脳室ドレーン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、急性期用脳室ドレーン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨急性期用脳室ドレーン市場における成功への道筋を描く

急性期用脳室ドレーン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 非外傷性水頭症の世界的有病率
    • 患者の神経学的状態の監視と管理の必要性
    • 低侵襲医療処置に対する患者の傾向
  • 抑制要因
    • 治療の時期と期間が不明
  • 機会
    • EVD移植におけるリアルタイム超音波ナビゲーションの利用増加
    • 世界中で医療ツーリズム活動が増加
  • 課題
    • 急性期用脳室ドレーンに関連するリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 急性期用脳室ドレーン市場患者タイプ別

• 成人用
• 小児科

第7章 急性期用脳室ドレーン市場：用途別

• 脳内出血
• 非外傷性水頭症
• くも膜下出血
• 外傷性脳損傷

第8章 南北アメリカの急性期用脳室ドレーン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の急性期用脳室ドレーン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの急性期用脳室ドレーン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• B. Braun Medical Inc.
• Bicakcilar Medical Devices Industry and Trade Inc.
• Brain Navi Biotechnology Co., Ltd.
• Cadila Pharmaceuticals Limited
• Cook Group Incorporated
• Dispomedica GmbH
• Fuji Systems Co. Ltd.
• G. Surgiwear Ltd.
• Geistlich Pharma Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• Medtronic Plc
• Merit Medical Systems
• Moller Medical Gmbh
• Natus Medical Incorporated
• Neuromedex GmbH
• Nipro Corporation
• Pfizer Inc.
• Raumedic AG
• Salvavidas Pharmaceutical Pvt. Ltd
• Silmag S.A.
• Sophysa SA
• Spiegelberg Gmbh & Co. Kg
• Wellong Instruments Co., Ltd.
• Yushin Medical Co., Ltd.

LIST OF FIGURES

• FIGURE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET RESEARCH PROCESS
• FIGURE 2. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS
• TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACEREBRAL HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY NON-TRAUMATIC HYDROCEPHALUS CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023

The Acute External Ventricular Drain Market was valued at USD 243.46 million in 2023, expected to reach USD 266.64 million in 2024, and is projected to grow at a CAGR of 9.95%, to USD 473.19 million by 2030.

Acute External Ventricular Drain (EVD) systems are critical devices designed for managing intracranial pressure by diverting cerebrospinal fluid (CSF) from the brain's ventricles in conditions like traumatic brain injury or hydrocephalus. The necessity of EVDs arises in acute clinical settings where rapid intervention is needed to prevent neuronal damage from increased intracranial pressure. These devices find primary applications in neurosurgery, intensive care units, and emergency medicine, serving end users such as hospitals and specialized neurological centers. The market growth for EVDs is significantly influenced by rising incidences of neurological disorders, advancements in neurosurgical procedures, and the increasing availability of healthcare infrastructure in emerging economies. Additionally, the rise in the geriatric population susceptible to neurological ailments further propels demand. Key consumers in the market can explore potential opportunities in untapped regions with growing healthcare budgets and leverage technological advancements like integrating smart monitoring systems for enhanced care. However, the market faces limitations in terms of high costs associated with installation and maintenance, potential risks of infection, and a shortage of skilled professionals to handle these systems effectively. Innovation could focus on developing cost-effective, lesser invasive EVD systems with enhanced safety and monitoring capabilities. The research could also explore material technologies that reduce infection risks and extend device longevity. Nonetheless, market players should address the challenges of stringent regulatory compliances and emphasize training programs to enhance skills in managing EVD systems. The nature of the EVD market is highly specialized, requiring continuous collaborations between medical device manufacturers and healthcare providers to foster innovations and tailor services to meet evolving clinical demands. In sum, a strategic focus on cost reduction, technological integration, and expanding into developing regions could significantly enhance market reach and effectiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute External Ventricular Drain Market

The Acute External Ventricular Drain Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of non-traumatic hydrocephalus globally
  • Need for monitoring and regulating the neurologic status of patients
  • Inclination of patients toward minimally invasive medical procedures
• Market Restraints
  • Uncertain time and duration of treatment
• Market Opportunities
  • Rising use of real-time ultrasound navigation for EVD implantation
  • Increasing medical tourism activities worldwide
• Market Challenges
  • Risks associated with acute external ventricular drain

Porter's Five Forces: A Strategic Tool for Navigating the Acute External Ventricular Drain Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute External Ventricular Drain Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute External Ventricular Drain Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute External Ventricular Drain Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute External Ventricular Drain Market

A detailed market share analysis in the Acute External Ventricular Drain Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute External Ventricular Drain Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute External Ventricular Drain Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute External Ventricular Drain Market

A strategic analysis of the Acute External Ventricular Drain Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include B. Braun Medical Inc., Bicakcilar Medical Devices Industry and Trade Inc., Brain Navi Biotechnology Co., Ltd., Cadila Pharmaceuticals Limited, Cook Group Incorporated, Dispomedica GmbH, Fuji Systems Co. Ltd., G. Surgiwear Ltd., Geistlich Pharma Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Merit Medical Systems, Moller Medical Gmbh, Natus Medical Incorporated, Neuromedex GmbH, Nipro Corporation, Pfizer Inc., Raumedic AG, Salvavidas Pharmaceutical Pvt. Ltd, Silmag S.A., Sophysa SA, Spiegelberg Gmbh & Co. Kg, Wellong Instruments Co., Ltd., and Yushin Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Patient Type, market is studied across Adult and Pediatric.
• Based on Application, market is studied across Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage, and Traumatic Brain Injury.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of non-traumatic hydrocephalus globally
    • 5.1.1.2. Need for monitoring and regulating the neurologic status of patients
    • 5.1.1.3. Inclination of patients toward minimally invasive medical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Uncertain time and duration of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising use of real-time ultrasound navigation for EVD implantation
    • 5.1.3.2. Increasing medical tourism activities worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Risks associated with acute external ventricular drain
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Acute External Ventricular Drain Market, by Patient Type

• 6.1. Introduction
• 6.2. Adult
• 6.3. Pediatric

7. Acute External Ventricular Drain Market, by Application

• 7.1. Introduction
• 7.2. Intracerebral Hemorrhage
• 7.3. Non-Traumatic Hydrocephalus Conditions
• 7.4. Subarachnoid Hemorrhage
• 7.5. Traumatic Brain Injury

8. Americas Acute External Ventricular Drain Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Acute External Ventricular Drain Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Acute External Ventricular Drain Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun Medical Inc.
• 2. Bicakcilar Medical Devices Industry and Trade Inc.
• 3. Brain Navi Biotechnology Co., Ltd.
• 4. Cadila Pharmaceuticals Limited
• 5. Cook Group Incorporated
• 6. Dispomedica GmbH
• 7. Fuji Systems Co. Ltd.
• 8. G. Surgiwear Ltd.
• 9. Geistlich Pharma Inc.
• 10. Integra LifeSciences Corporation
• 11. Johnson & Johnson Services, Inc.
• 12. Medtronic Plc
• 13. Merit Medical Systems
• 14. Moller Medical Gmbh
• 15. Natus Medical Incorporated
• 16. Neuromedex GmbH
• 17. Nipro Corporation
• 18. Pfizer Inc.
• 19. Raumedic AG
• 20. Salvavidas Pharmaceutical Pvt. Ltd
• 21. Silmag S.A.
• 22. Sophysa SA
• 23. Spiegelberg Gmbh & Co. Kg
• 24. Wellong Instruments Co., Ltd.
• 25. Yushin Medical Co., Ltd.